SMA News Today article, cited Aug 2020 3. Evrysdi (Risdiplam)SMA News Today article, cited Aug 2020 4. FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and olderRoche press release, August 7, 2020 5. FDA Approves Oral Treatment for Spinal Muscular Atrophy FDA press release, August 7, 2020 6. EvrysdiEMA product overview, cited Apr 2021